Trade Tarsus Pharmaceuticals, Inc. - TARS CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.31 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023568% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001346% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 0.1 | ||||||||
| Currency | USD | ||||||||
| Margin | 50.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 49.43 |
| Open | 47.31 |
| 1-Year Change | 32.19% |
| Day's Range | 45.82 - 48.17 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Apr 4, 2025 | 46.93 | -0.68 | -1.43% | 47.61 | 48.54 | 45.74 |
| Apr 3, 2025 | 49.43 | -0.03 | -0.06% | 49.46 | 51.30 | 47.55 |
| Apr 2, 2025 | 51.38 | 3.77 | 7.92% | 47.61 | 51.75 | 47.61 |
| Apr 1, 2025 | 48.87 | -2.08 | -4.08% | 50.95 | 50.95 | 48.64 |
| Mar 31, 2025 | 51.31 | 1.41 | 2.83% | 49.90 | 51.48 | 47.45 |
| Mar 28, 2025 | 51.62 | 3.00 | 6.17% | 48.62 | 52.02 | 48.62 |
| Mar 27, 2025 | 50.54 | 1.55 | 3.16% | 48.99 | 51.15 | 48.79 |
| Mar 26, 2025 | 50.94 | 1.04 | 2.08% | 49.90 | 51.22 | 49.42 |
| Mar 25, 2025 | 51.24 | 1.16 | 2.32% | 50.08 | 52.08 | 50.08 |
| Mar 24, 2025 | 52.42 | 3.89 | 8.02% | 48.53 | 52.47 | 48.23 |
| Mar 21, 2025 | 49.86 | 0.65 | 1.32% | 49.21 | 50.91 | 48.02 |
| Mar 20, 2025 | 49.80 | 0.75 | 1.53% | 49.05 | 50.71 | 49.05 |
| Mar 19, 2025 | 49.46 | 5.05 | 11.37% | 44.41 | 49.54 | 44.41 |
| Mar 18, 2025 | 46.11 | -0.24 | -0.52% | 46.35 | 46.87 | 45.32 |
| Mar 17, 2025 | 47.39 | 0.45 | 0.96% | 46.94 | 48.26 | 46.77 |
| Mar 14, 2025 | 48.04 | 2.51 | 5.51% | 45.53 | 48.13 | 45.36 |
| Mar 13, 2025 | 46.43 | -1.03 | -2.17% | 47.46 | 48.35 | 45.10 |
| Mar 12, 2025 | 47.03 | -0.07 | -0.15% | 47.10 | 48.70 | 46.78 |
| Mar 11, 2025 | 46.96 | 3.01 | 6.85% | 43.95 | 47.13 | 43.79 |
| Mar 10, 2025 | 44.53 | -0.67 | -1.48% | 45.20 | 45.66 | 43.63 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 20
- 100
- 500
- 1000
- 10000
Tarsus Pharmaceuticals, Inc. Company profile
About Tarsus Pharmaceuticals Inc
Tarsus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapeutic candidates to address ophthalmic conditions. Its lead product candidate, TP-03, is a therapeutic being developed for the treatment of blepharitis caused by the infestation of Demodex mites (Demodex blepharitis). TP-03 is a therapeutic based on the drug, lotilaner, which is designed to paralyze and eradicate mites and other parasites through the inhibition of parasite-specific gamma-aminobutyric acid-gated chloride (GABA-Cl) channels. The Company is also developing additional clinical-stage product candidates with lotilaner. These include TP-04 for the treatment of rosacea as well as TP-05 for Lyme prophylaxis and community malaria reduction.
Financial summary
BRIEF: For the nine months ended 30 September 2021, Tarsus Pharmaceuticals Inc revenues increased from $0K to $56.7M. Net income applicable to common stockholders totaled $1M vs. loss of $15.3M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Basic Earnings per Share excluding Extraordinary Items increased from -$0.82 to $0.05.
| Industry: | Pharmaceuticals (NEC) |
15440 Laguna Canyon Road
IRVINE
CALIFORNIA 92618
US
News
Copper price forecast: third-party price target
What’s next for the copper market? Read on for the latest analysis of the commodity's price and potential outlook.
17:31, 14 March 2025
Coffee price forecast: 2025-2030 third-party coffee target
Coffee prices have cooled considerably in the past few months. Is a rebound in store or will they continue to fall?
09:42, 12 March 2025
The Simpsons predicted XRP to hit $589: Has the show got it right again?
Did the animated TV show predict a breakout for the XRP cryptocurrency?
11:00, 11 March 2025
Rolls-Royce share price forecast: third- party price target
Our Rolls-Royce share price forecast looks at the outlook for the FTSE 100-listed engineering company after a tough few years.
14:58, 10 March 2025
Gasoline petrol price forecast 2025-2030: Third-party price target
Discover third-party gasoline (petrol) price predictions for 2025 and beyond, with analyst targets, historical prices, and trading strategies.
10:27, 3 March 2025
USD forecast - third party data round up
The DXY hit a seven-month low in January, just a few months after a multi-decade peak in late September.
10:02, 27 February 2025
Microsoft Stock Price Forecast for 2025 and beyond: Third party price target
We assess the likely level of the Microsoft stock price in 5 years, and possible drivers behind the stock’s past performance. Read on...
18:29, 7 February 2025People also watch
Still looking for a broker you can trust?
Join the 710,000+ traders worldwide that chose to trade with Capital.com